Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B

Hepatology Research

Volumn 43, Issue 3, 2013, Pages 228-237

  Gümüşay, Özge ^a   Özenirler, Seren ^a   Atak, Ayşegül ^a   Sönmez, Cemile ^a   Özkan, Seçil ^a   Tuncel, Ayşe Fitnat ^a   Yilmaz, Güldal ^a   Akyol, Gülen ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Aspartate aminotransferase to platelet ratio index; Enhanced Liver Fibrosis Panel; Hyaluronic acid; Liver fibrosis chronic hepatitis B; Non invasive diagnosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HYALURONIC ACID; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENHANCED LIVER FIBROSIS PANEL; FEMALE; HEPATITIS B; HEPATOBILIARY PARAMETERS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; ORIGINAL EUROPEAN LIVER FIBROSIS PANEL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 84874308367     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01057.x     Document Type: Article

References (31)

1. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008; 48: 335-52.
2. Wu X-J, Wang Y, Chen J, Wang G-Q. Baseline predictors of virological response for chronic hepatitis B patients. World J Gastroenterol 2009; 15: 4311-5.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
4. Shi Y-H, Shi C-H. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15: 3099-105.
5. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
6. Gutierrez-Reyes G, Gutierrez-Ruiz MC, Kershenobich D. Liver fibrosis and chronic viral hepatitis. Arch Med Res 2007; 38: 644-51.
7. Zeisberg M, Yang C, Martino M etal. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282: 23337-47.
8. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver diseases. Liver biopsy. Hepatology 2009; 49 (3): 1017-44.
9. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.
10. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
11. Maharaj B, Maharaj RJ, Leary WP etal. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-5.
12. Regev A, Berho M, Jeffers LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-8.
13. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
14. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006; 15: 149-59.
15. Rosenberg WM, Voelker M, Thiel R etal. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-13.
16. Guha IN, Parkes J, Roderick P etal. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008; 47: 455-60.
17. Parkes J, Guha IN, Roderick P etal. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat 2011; 18: 23-31.
18. Lee MH, Cheong JY, Um SH etal. Comparison of surrogate serum markers and transient elastography (fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci 2010; 55: 3552-60.
19. Ishak K, Baptista A, Bianchi L etal. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
20. Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol 1995; 22: 103-6.
21. Schuppan D. Connective tissue polypeptide in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol 1991; 13: 17-25.
22. Leroy V, Monier F, Bottari S etal. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004; 99: 271-9.
23. Kim SM, Sohn JH, Kim TY etal. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Korean J Hepatol 2009; 15: 454-63.
24. Montazeri G, Estakhri A, Mohamadnejad M etal. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005; 5: 32-38.
25. Boeker KH, Haberkorn CI, Michels D etal. Diagnostic potential of circullating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta 2002; 316: 71-81.
26. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
27. Kim BK, Kim do Y, Park JY etal. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010; 30: 546-53.
28. Bourliere M, Penaranda G, Renou C etal. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006; 13: 659-70.
29. Bourlière M, Pénaranda G, Adhoute X, Oules V, Castellani P. Combining non-invasive methods for assessment of liver fibrosis. Gastroenterol Clin Biol 2008; 32: 73-9.
30. Sebastiani G, Halfon P, Castera L etal. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1821-7.
31. Castéra L, Sebastiani G, Le Bail B, de Lédinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 2010; 52: 191-8.